Products
This page is generated by the site theme. Please open the live page to view the current content.
A complete product chain from fermentation-derived intermediates to finished active pharmaceutical ingredients, released against current BP, EP, USP and CP specifications.
Hebei Xingang Pharmaceutical specialises in the research, development, production and sale of rifamycin biotechnology fermentation products, pharmaceutical intermediates, APIs and related products.
Our APIs are manufactured in dedicated GMP workshops and meet the latest version of the relevant pharmacopoeia monograph.
USP / EP / BP
Flagship anti-tuberculosis API, CAS 13292-46-1. Also supplied as Rifampin.
USP / EP / BP
Long-acting rifamycin API used in combination tuberculosis therapy.
USP / EP / BP
Poorly absorbed rifamycin derivative for gastrointestinal applications.
USP / EP / BP
Rifamycin S derivative used against mycobacterial infections.
CP
Rifamycin series API produced to Chinese Pharmacopoeia standard.
USP / EP / BP
CAS 14897-39-3, fermentation-derived sodium salt.
High-purity building blocks for downstream rifamycin API synthesis, supplied with consistent quality and full batch traceability.
min. 99%
Core oxidation intermediate of the rifamycin series.
min. 99%
Also known as Rifamycin S-Na salt or Sodium Rifamycin S.
Fermentation
Fermentation-derived sodium salt intermediate.
Intermediates
Specialised rifamycin intermediates including 3-F.
Every batch is verified against strict specifications before release. Our quality system covers raw material inspection, in-process control, finished product testing, stability studies, process and method validation, and complete batch documentation for end-to-end traceability.
Our international trade team answers product and audit enquiries quickly.
Request a Quote